GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, ESR1, F10, F3, FABP3, FABP4, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HRH1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, KCNH2, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS1, PTGS2, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
14.9185 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPI, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, TRPV1 |
11.4613 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AR, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, GPER1, GRIK5, GRM5, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SLC6A4, SRC, TRPV1, TYR |
10.9817 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, AXL, BCL2, CA2, CA9, CDK6, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM5, HRH1, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, MMP2, MMP9, NR3C1, PIK3CA, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, RORC, SLC6A2, SLC6A4, SRC, TERT, TRPV1, TYR |
10.3297 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM5, HRH1, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, NR3C1, PIK3CA, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, RORC, SLC6A4, SRC, TRPV1, TYR |
10.2592 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.0487 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
9.98993 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
9.40283 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 |
9.32196 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.28297 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD11B2, NR3C1, PPARA, PRKCD, PRKCE, PTGS2, SLC6A4, SRC, TRPV1 |
9.2616 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, FLT3, GPER1, HRH1, HSD11B2, NR3C1, PRKCE, PRKCG, PTGS2, RORC, SLC6A4, SRC, TRPV1, TYR |
9.2616 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 |
9.2616 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 |
9.10462 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, GRM5, HRH1, HSD11B2, IGF1R, MMP2, NR3C1, PPARA, PRKCD, PRKCE, PTGS2, SLC6A4, SRC, TRPV1 |
8.85941 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM5, HRH1, IGF1R, KCNH2, KDR, MMP2, MMP9, NR3C1, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SLC6A4, SRC, TERT, TRPV1 |
8.81697 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD11B2, HSD17B2, NR3C1, PRKCE, PTGS2, RORC, SLC6A4, SRC, TYR |
8.61342 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GPER1, GRIK5, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TERT, TOP2A, TRPV1, XDH |
8.57653 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, FUT7, GBA2, GLO1, HSD17B3, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
8.53641 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GPER1, GRIK5, HCAR2, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TERT, TOP2A, TRPV1, XDH |
8.4276 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM5, HRH1, IGF1R, KDR, MMP2, NR3C1, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SLC6A4, SRC, TRPV1 |
8.28325 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
8.12928 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GPER1, GRIK5, GRM1, GRM5, HCAR2, HRH1, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
8.10904 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GPER1, GRIK5, HCAR2, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TERT, TOP2A, TRPV1, XDH |
8.10904 |
[BP] GO:0007193 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8 |
7.98024 |
[BP] GO:0015872 |
None
|
CHRM5, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
7.82684 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, GPER1, GRM1, HCAR2, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.77987 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, GPER1, GRM1, HCAR2, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.74793 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AR, AXL, CDK6, CYP1B1, ESR1, GPER1, GRIK5, GRM5, IGF1R, MMP2, MMP9, NR3C1, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, RORC, SLC6A4, SRC, TRPV1 |
7.56775 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, NQO2, PTGS1, RORC |
7.55665 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, HCAR2, HRH1, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC1A1, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
7.35281 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 |
7.32872 |
[BP] GO:0051937 |
None
|
CHRM5, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
7.19242 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PPARA, PTGS1, PTGS2 |
7.12612 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX5, ALPI, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, FABP4, FUT7, GBA2, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
7.02736 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPI, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES1, CES2, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
7.02362 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR3C1, NR3C2, PGR, PPARA, RORC, SRC |
7.01955 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, NQO2, PTGS1, PTGS2, TYR, XDH |
6.95136 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, SLC1A1, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
6.93348 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2 |
6.93212 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR3C1, PGR, PIM1, PPARA, RORC, SRC |
6.8115 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPI, ALPL, AR, AXL, BCL2, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F10, F3, FABP4, GPER1, GRM1, GRM5, GRM8, HRH1, HSD11B2, HSD17B2, IGF1R, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PRKCD, PRKCG, PTGS2, RORC, SLC6A2, SLC6A4, SRC, TNKS2, TRPV1, TYR |
6.80743 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, AR, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, GPER1, IGF1R, KDR, MMP12, MMP2, MMP9, PGR, PIM1, PRKCA, PTGS1, PTGS2, SLC6A4, SRC, TERT, XDH |
6.71134 |
[BP] GO:0030168 |
platelet activation
|
ADRA2A, AXL, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
6.57672 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, GPER1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, PRKCA, PRKCE, SLC22A1 |
6.56868 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, APEX1, AR, AXL, BCL2, CA2, CA7, CDK6, CHRM1, CSNK2A1, CYP19A1, CYP1B1, F10, F3, GPER1, GRIK5, GRM5, HCAR2, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SLC6A4, SRC, TERT, TRPV1 |
6.47407 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, FABP3, HSD11B2, KCNH2, KDR, NR3C1, PRKCD, PRKCE, PRKCG, PTGS2, SLC6A2, SLC6A4, SRC, TRPV1 |
6.35498 |
[BP] GO:0015844 |
None
|
CHRM5, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
6.32321 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
6.32321 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM2, CHRM3, CHRM5, GPER1, GRM1, GRM3, GRM5, GRM8 |
6.30913 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AR, AXL, BCL2, CSNK2A1, CYP1B1, F10, F3, FLT3, GPER1, GRM1, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
6.30913 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, AR, CYP1A1, CYP1B1, ESR1, FLT3, GPER1, HRH1, NR3C1, PTGS2, RORC, SLC6A4, SRC, TRPV1 |
6.27704 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CDK6, GPER1, HCAR2, KDR, PIK3CB, PRKCE, PTGS2, SRC, TNKS, TNKS2, TRPV1 |
6.22882 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8, HRH1, PRKCE, PTGS2, SLC6A4 |
6.21265 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8, HRH1, PRKCE, PTGS2, SLC6A4 |
6.21265 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, GBA2, GLO1, PPARA, PTGS1, PTGS2 |
6.18871 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, HRH1, IGF1R, KCNH2, KDR, MMP2, MMP9, NR3C1, PIK3CA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TOP2A, TRPV1 |
6.01489 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALPL, APEX1, AR, AURKB, AXL, BCL2, CA2, CA6, CA9, CDK6, CES1, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, HRH1, HSD11B2, HSD17B2, IGF1R, KCNH2, KDR, MMP12, MMP2, MMP9, NR3C1, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC6A2, SLC6A4, SRC, TERT, TOP2A, TRPV1, TYR |
6.0074 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
5.91079 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TERT |
5.90766 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MET, MMP9, PIK3CA, PIM1, PPARA, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TERT |
5.9049 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPI, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES1, CES2, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MET, MMP1, MMP2, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC22A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
5.9049 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM5, FABP3, GRIA2, GRIA4, GRIK5, KCNH2, PPARA, PRKCB, PRKCE, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC6A2, SLC6A4, TRPV1 |
5.90471 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
5.88048 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, ALOX12, AR, BCL2, CDC25B, CDK6, CHRM1, CSNK2A1, ESR1, F3, FLT3, GPER1, IGF1R, KDR, MMP12, MMP2, MMP9, PIM1, PRKCA, PTGS2, TERT |
5.78969 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, ALOX12, APEX1, BCL2, CDK6, CHRM1, CYP19A1, CYP1B1, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
5.74082 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AR, AXL, BCL2, CYP1B1, F10, F3, FLT3, GPER1, GRM1, KDR, MET, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCE, PTGS2, PTPN1, SRC, XDH |
5.72026 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM2, CHRM3, CHRM5, GPER1, GRM1, GRM3, GRM5, GRM8 |
5.68404 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, KCNH2, KDR, NR3C1, PRKCD, PRKCE, PTGS2, SRC, TRPV1 |
5.6641 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
5.6456 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, ALOX12, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
5.6456 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, ALOX12, APEX1, AXL, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, GPER1, GRIK5, GRM1, GRM5, KCNH2, MET, PIK3CA, PIK3CB, PRKCB, PRKCE, SRC, TERT, TRPV1 |
5.54574 |
[BP] GO:0015893 |
None
|
CA2, CHRM5, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4 |
5.50411 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
5.50131 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, SLC1A1, SLC22A1, SLC22A2, SLC22A3, TRPV1 |
5.45923 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, AR, AXL, BCL2, CA1, CA2, CDK6, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, IGF1R, KCNH2, KDR, MET, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1 |
5.42592 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, ALOX12, APEX1, BCL2, CYP19A1, CYP1B1, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
5.4098 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AR, AURKB, AXL, BCL2, CSNK2A1, GLO1, IGF1R, KDR, MMP9, PIK3CA, PIM1, PRKCA, PRKCD, PRKCG, PTGS2, PTPN1, SRC, TERT |
5.39363 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALPI, CES1, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, PIK3CA, PIK3CB, PTGS1, PTGS2 |
5.38877 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F10, F3, FLT3, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
5.33747 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CHRM5, CYP1A1, FABP3, FLT3, GPER1, HCAR2, PPARA, PRKCD, PRKCE, PTGS2, RORC, SRC |
5.32372 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, AR, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F10, F3, FLT3, GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SLC6A4, SRC, TERT, TNKS, TNKS2, XDH |
5.25354 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
5.23128 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.18898 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.18898 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SLC6A4, SRC, TERT |
5.18483 |
[BP] GO:0007200 |
None
|
ADRA2A, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, GRM5, HRH1 |
5.15426 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, ALOX12, BCL2, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
5.12782 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, ALOX12, APEX1, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
5.11083 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, AR, AXL, BCL2, CSNK2A1, CYP1B1, ESRRA, F10, F3, FABP4, FLT3, GPER1, GRM1, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
5.09835 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SLC6A4, SRC, TERT |
5.05936 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, ALOX12, AR, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CHRM3, CYP1B1, ESR1, ESRRA, ESRRB, F3, GPER1, GRM1, HCAR2, HRH1, KCNH2, KDR, MET, MMP12, MMP9, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, SLC1A1, SLC6A4, SRC, TERT, TNKS2, TRPV1, XDH |
5.03471 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.98669 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, ALOX12, BCL2, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
4.9452 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, MMP9, PRKCD, PTGS2, SRC, TERT |
4.90227 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, GRM1, GRM5, HRH1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
4.88683 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, GPER1, GRM1, GRM5, HRH1, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.88316 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, AR, BCL2, CDC25B, ESRRB, FABP3, FLT3, GPER1, GRM1, GRM5, HRH1, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.88316 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, FABP3, FLT3, GPER1, GRM5, HRH1, HSD11B2, IGF1R, MMP2, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SLC6A4, SRC, TRPV1, TYR |
4.88316 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, AR, ESR1, FLT3, GPER1, GRM5, HRH1, IGF1R, MMP2, NR3C1, PRKCD, PRKCE, PTGS2, SLC6A4, SRC, TRPV1 |
4.87619 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, GRM1, GRM5, HRH1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
4.8559 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
4.84495 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM2, CHRM3, GPER1, PTGS2 |
4.82538 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, ALOX12, BCL2, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
4.82104 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, ALOX12, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, GPER1, GRIK5, GRM1, GRM5, KCNH2, MET, PIK3CA, PIK3CB, PRKCB, PRKCE, TRPV1 |
4.76255 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.71354 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SLC6A4, SRC, TERT |
4.70914 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIK5, GRM1, GRM3, GRM5, PRKCG, SLC1A1, SLC6A2 |
4.69863 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIK5, GRM1, GRM3, GRM5, PRKCG, SLC1A1, SLC6A2 |
4.69863 |
[BP] GO:0007154 |
None
|
ADORA1, AR, AXL, BCL2, CHRM1, CHRM2, CHRM3, CHRM5, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, PGR, PRKCG, PTGS2, SLC1A1, SLC6A2, TRPV1 |
4.69863 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, ALOX12, BCL2, F10, F3, GPER1, IGF1R, KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC, TERT |
4.64786 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, AR, BCL2, CDC25B, CHRM5, ESRRB, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, HRH1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.64786 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPER1, GRM3, GRM8, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, NR3C1, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
4.61095 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIK5, GRM1, GRM3, GRM5, PRKCG, SLC1A1, SLC6A2 |
4.60385 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIK5, GRM1, GRM3, GRM5, PRKCG, SLC1A1, SLC6A2 |
4.60385 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, AR, BCL2, CDC25B, CHRM5, ESRRB, FABP3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, GRM8, HRH1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.58726 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.53144 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
4.52579 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, AR, BCL2, CDC25B, ESRRB, FLT3, GPER1, GRM1, GRM5, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.47547 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, FABP3, FLT3, GPER1, GRM5, HRH1, HSD11B2, IGF1R, MMP2, PPARA, PRKCD, PRKCE, PRKCG, PTGS2, SLC6A4, SRC, TRPV1, TYR |
4.44334 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, GPER1, GRIK5, PTGS2, SLC1A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4, TRPV1 |
4.42023 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM3, GPER1, HRH1, PTGS2, SLC6A4, SRC |
4.39937 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR3C1, NR3C2, PGR, PPARA, RORC |
4.36393 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
4.35844 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, CHRM1, CHRM2, CHRM3, GPER1, GRM1, HCAR2, HRH1, KCNH2, PRKCA, PTGS2, SLC1A1, TRPV1 |
4.35781 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, NR3C1, PGR, SRC |
4.35781 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F10, F3, FLT3, GPER1, GRM1, IGF1R, KDR, MET, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.28718 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS |
4.24525 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS |
4.19623 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, AR, BCL2, CDC25B, FLT3, GPER1, GRM1, GRM5, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
4.18234 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, GBA2, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
4.18234 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, HRH1, PPARA, PRKCE, SRC |
4.18234 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA, PRKCD, PRKCE |
4.18234 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, ALOX12, CHRM1, CHRM3, F10, F3, MET, PRKCA, PRKCD, PRKCE, SLC22A2, XDH |
4.14659 |
[BP] GO:0023052 |
None
|
ADORA1, AR, CHRM1, CHRM2, CHRM3, CHRM5, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, KCNH2, PGR, PRKCG, SLC1A1, SLC6A2 |
4.14351 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ALOX12, AR, AXL, BCL2, CA2, CHRM3, CYP1B1, ESRRB, F3, GPER1, HCAR2, HRH1, KDR, MET, MMP12, MMP9, PIM1, PRKCA, PRKCB, PRKCE, PTGS2, SLC1A1, SRC, TERT, TRPV1 |
4.14351 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, GPER1, HSD11B2, NR3C1, PTGS2, SRC |
4.14351 |
[BP] GO:0015696 |
None
|
CHRM5, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
4.14351 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CES1, CYP1A1, CYP1B1, KDR, PRKCD, PRKCE, SLC6A4, SRC |
4.1369 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM3, GPER1, HRH1, PTGS2, SLC6A4 |
4.1369 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM3, GPER1, HRH1, PTGS2, SLC6A4 |
4.1369 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CA7, CHRM1, CYP19A1, GPER1, GRIK5, GRM5, HCAR2, KCNH2, MMP12, MMP9, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SLC6A4, SRC, TERT, TRPV1 |
4.1369 |
[BP] GO:0007267 |
None
|
ADORA1, AR, CHRM1, CHRM2, CHRM3, CHRM5, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, PGR, PRKCG, SLC1A1, SLC6A2 |
4.09205 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.09082 |
[BP] GO:0015874 |
None
|
SLC22A1, SLC22A2, SLC6A2 |
4.08577 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.08577 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPER1, GRM3, GRM8, HCAR2, IGF1R, KCNH2, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
4.0728 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, PGR, PPARA, PRKCG, RORC, SLC6A4, SRC, TOP2A |
4.03675 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
ALOX12, CYP1B1, F3, GPER1, KDR, PRKCA, PRKCB, PTGS2, TERT |
4.03443 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPI, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CES1, CES2, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
4.03047 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APEX1, AR, AURKB, AXL, BCL2, CA2, CA9, CDC25B, CDK6, CES1, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD17B2, HSD17B3, KDR, MET, MMP2, MMP9, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCD, PTGS2, RORC, SLC6A4, SRC, TERT, TNKS2, TOP2A, TYR |
4.01395 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APEX1, AR, AURKB, BCL2, CSNK2A1, CYP2D6, ESR1, ESR2, ESRRA, FABP4, GPER1, GRM3, GRM8, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, PGR, PIK3CA, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
4.01078 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, FABP3, GPER1, GRM5, HSD11B2, IGF1R, PPARA, PRKCD, PTGS2, SRC, TRPV1 |
4.0078 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
3.97022 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM3, GPER1, HRH1, PTGS2, SLC6A4 |
3.96619 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM3, GPER1, HRH1, PTGS2, SLC6A4 |
3.94334 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, GRM1, GRM3, GRM5, GRM8, PTGS2 |
3.91345 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, BCL2, CHRM1, CHRM3, CHRM5, CYP1A1, ESR1, FLT3, MET, PIK3CB, PIM1, PRKCD, SRC, TYR |
3.88065 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS |
3.87505 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, AXL, BCL2, CA1, CSNK2A1, F3, FLT3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTPN1, SRC, TNKS, TNKS2, TRPV1 |
3.81876 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.73224 |
[BP] GO:0006855 |
None
|
SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2 |
3.71819 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, PRKCE, SRC, TNKS, TNKS2, TRPV1 |
3.70258 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, GBA2, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.63287 |
[BP] GO:0001504 |
None
|
SLC1A1, SLC22A3, SLC6A2, SLC6A4 |
3.63287 |
[BP] GO:0045913 |
None
|
ESRRB, GPER1, HRH1, PPARA, PRKCE, SRC |
3.57716 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS |
3.54494 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, AXL, BCL2, CA2, CHRM1, CYP19A1, GPER1, HCAR2, KCNH2, MMP12, PRKCD, PRKCE, PTGS2, SLC6A4, SRC, TERT, TRPV1 |
3.54156 |
[BP] GO:0072488 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC6A4 |
3.53673 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, GBA2, GLO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.53396 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM3, GPER1, HRH1, PTGS2, SLC6A4, SRC |
3.52555 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, PRKCD, SRC |
3.52486 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, PRKCD, SRC |
3.52486 |
[BP] GO:0045766 |
positive regulation of angiogenesis
|
ALOX12, CYP1B1, F3, KDR, PRKCA, PRKCB, PTGS2, TERT |
3.51409 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, GPER1, GRM5, HRH1, IGF1R, MMP2, PRKCD, PTGS2, SLC6A4, SRC, TRPV1 |
3.50876 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, GPER1, HSD11B2, NR3C1, PTGS2, SRC |
3.49672 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, GPER1, KDR, PRKCE, SRC, TRPV1 |
3.48643 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, AURKB, CSNK2A1, CYP1B1, CYP2D6, ESR1, FABP4, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TNKS |
3.48643 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19, CYP2D6 |
3.47459 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, F10, F3, GPER1, MET, PIK3CA, PIK3CB, SRC, XDH |
3.44259 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, PIK3CA, PPARA, SRC, TYR |
3.37883 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, AR, BCL2, CDC25B, ESRRB, FABP4, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
3.33386 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, GRM1, HRH1, HSD11B2, MMP2, PPARA, PRKCB, PRKCE, PTGS2, SLC6A4, SRC, TERT, TRPV1, TYR |
3.31879 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5, TRPV1 |
3.29717 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APEX1, AR, AURKB, BCL2, CSNK2A1, CYP2D6, ESR1, ESR2, ESRRA, FABP4, GPER1, GRM3, GRM8, IGF1R, MET, MMP12, MMP9, NR3C1, PIK3CA, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
3.28035 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, XDH |
3.27892 |
[BP] GO:0018107 |
peptidyl-threonine phosphorylation
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD, TNKS |
3.27619 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PRKCD, PRKCE |
3.25678 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, CHRM1, CHRM2, CHRM3, HRH1, KCNH2, PTGS2, SLC1A1 |
3.25228 |
[BP] GO:0010675 |
None
|
ESRRB, GPER1, HRH1, PPARA, PRKCE, RORC, SRC |
3.23874 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPI, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CDC25B, CDK6, CES1, CES2, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
3.23874 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, GPER1, HCAR2, PIK3CB, PTGS2, TNKS, TNKS2 |
3.22907 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, CDK6, ESR1, FLT3, GPER1, NR3C1, PRKCE, RORC, SLC6A4, SRC |
3.20338 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, GPER1, GRM5, HRH1, IGF1R, MMP2, PRKCD, PTGS2, SLC6A4, SRC, TRPV1 |
3.199 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PRKCD, PRKCE, PTGS2, SRC |
3.199 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, PRKCD, SRC |
3.17123 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, PRKCE, PTGS2, SRC |
3.15608 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.14758 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.14758 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, AR, FLT3, GPER1, GRM1, KDR, PIK3CB, PRKCA, PRKCE, PTPN1, SRC, XDH |
3.14105 |
[BP] GO:0018210 |
peptidyl-threonine modification
|
BCL2, CSNK2A1, PRKCA, PRKCB, PRKCD, TNKS |
3.08354 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.07505 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, ALOX12, CDK6, CYP19A1, ESR1, F3, FABP4, GPER1, IGF1R, MET, MMP12, MMP2, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TERT, XDH |
3.06171 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, F3, GPER1, GRIK5, HCAR2, MMP9, PIK3CB, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
3.01103 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, BCL2, CA2, CA7, CHRM1, GPER1, GRM5, KCNH2, MMP9, PRKCD, PRKCE, PTGS2, SLC6A4 |
3.00458 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPI, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES1, CES2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC22A1, SLC22A2, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
2.97416 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, F10, FLT3, IGF1R, KDR, MET, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TNKS, TOP2A |
2.97266 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, F3, GPER1, GRIK5, HCAR2, MMP9, PIK3CB, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
2.96949 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, AR, BCL2, CDC25B, FABP4, FLT3, GPER1, GRM1, GRM5, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.95736 |
[BP] GO:0003008 |
None
|
ADORA1, ADRA2A, AKR1B1, BCL2, CHRM1, CHRM3, CHRM5, CYP1B1, GPER1, GRM1, GRM5, GRM8, HRH1, HSD11B2, KCNH2, PIK3CA, PRKCG, PTGS2, SLC6A4, SRC, TRPV1, TYR |
2.92476 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
2.88131 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPI, ALPL, APEX1, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TNKS, XDH |
2.8793 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, BCL2, KCNH2, MMP9, PRKCE, PTGS2 |
2.84485 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, AR, FLT3, GPER1, GRM1, IGF1R, KDR, PIK3CB, PRKCA, PRKCD, PRKCE, PTPN1, SRC, XDH |
2.84485 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, PRKCG, SRC |
2.83078 |
[BP] GO:0016572 |
histone phosphorylation
|
AURKB, PRKCA, PRKCB, PRKCD |
2.82519 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, AR, AURKB, BCL2, CDC25B, ESR1, ESR2, F3, FLT3, GPER1, GRM1, GRM5, MET, MMP9, PIK3CA, PIK3CB, PRKCB, PRKCD, PRKCE, PTPN1, SRC, TERT, TNKS, XDH |
2.81185 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, AR, BCL2, CDC25B, FLT3, GPER1, GRM1, GRM5, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.78602 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
2.78305 |
[BP] GO:0042391 |
None
|
ADORA1, BCL2, GPER1, GRIA2, GRIA4, GRIK5, GRM5, KCNH2, KDR, SRC, TRPV1 |
2.77941 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, APEX1, BCL2, CSNK2A1, ESRRB, HCAR2, KDR, MET, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTPN1 |
2.77025 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
2.75617 |
[BP] GO:1901342 |
regulation of vasculature development
|
ALOX12, CYP1B1, F3, GPER1, KDR, PRKCA, PRKCB, PTGS2, TERT, XDH |
2.74951 |
[BP] GO:0019229 |
None
|
ADRA2A, CHRM1, CHRM3, HRH1, PTGS2 |
2.72326 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
2.71688 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, PRKCD, SRC, TERT |
2.70813 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, PRKCD |
2.69379 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ADRA2A, ALOX5, AR, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, F10, FABP3, GRIA2, GRIA4, GRIK5, KCNH2, MMP12, MMP9, PPARA, PRKCB, PRKCD, PRKCE, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TERT, TNKS, TRPV1, XDH |
2.68342 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.66488 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F10, F3, MET, PIK3CA, PIK3CB, SRC |
2.66354 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, BCL2, CES1, CYP19A1, CYP1A1, CYP1B1, GBA2, HSD17B3, TYR |
2.66236 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, F3, GPER1, GRIK5, HCAR2, MMP9, PIK3CB, PRKCD, PTGS2, SRC, TOP2A, TRPV1, XDH |
2.65335 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, MMP9, PRKCD, PTGS1, PTGS2, SRC |
2.64477 |
[BP] GO:0051098 |
regulation of binding
|
AURKB, BCL2, CYP2D6, MET, MMP9, PPARA, PRKCD, SRC, TERT, TNKS |
2.64477 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, APEX1, AR, ESR1, FLT3, GPER1, NR3C1, PRKCD, PRKCE, SRC |
2.64477 |
[BP] GO:0035408 |
None
|
PRKCA, PRKCB |
2.64477 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.64477 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, PRKCE |
2.63021 |
[BP] GO:0051179 |
None
|
ACHE, ADORA1, ADRA2A, ALOX5, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, ESR1, F10, FABP3, GRIA2, GRIA4, GRIK5, KCNH2, MMP12, MMP9, PPARA, PRKCB, PRKCD, PRKCE, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
2.6296 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PRKCA, PTPN1, SRC |
2.62336 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, ESR1, FABP3, GPER1, GRM1, GRM5, KCNH2, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.61533 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, GPER1, HSD11B2, PPARA, PRKCD, PTGS2, SRC, TRPV1 |
2.60601 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ADRA2A, ALOX5, AR, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, F10, FABP3, GRIA2, GRIA4, GRIK5, KCNH2, MMP12, MMP9, PPARA, PRKCB, PRKCD, PRKCE, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TNKS, TRPV1, XDH |
2.59347 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
2.5923 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, AR, AURKB, BCL2, CA9, CDC25B, CDK6, CHRM5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GPER1, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
2.58097 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP2C19 |
2.57598 |
[BP] GO:0015697 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.57598 |
[BP] GO:0001775 |
cell activation
|
ADRA2A, ALOX5, AXL, BCL2, FLT3, FUT7, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, RORC, SRC, TRPV1 |
2.55959 |
[BP] GO:0006937 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM2, CHRM3, GPER1, PTGS2 |
2.54082 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX12, AR, BCL2, CDK6, CYP19A1, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, PPARA, PRKCB, PRKCD, PTGS2, PTPN1, SRC, TERT, XDH |
2.54082 |
[BP] GO:1900076 |
regulation of cellular response to insulin stimulus
|
ESRRA, PRKCB, PRKCD, PTPN1, SRC |
2.54082 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, PGR, PTGS2, SRC |
2.50688 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HSD17B3 |
2.48294 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, TRPV1 |
2.48294 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AR, BCL2, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, PRKCB, PRKCD, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
2.48294 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, AR, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, F3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, IGF1R, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
2.48294 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, HRH1, IGF1R, KDR, MET, MMP12, NR3C1, PGR, PPARA, PRKCD, PTGS2, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1 |
2.48294 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, ESR1, F3, FABP4, GPER1, KDR, MET, MMP12, PPARA, PRKCA, PRKCD, PRKCG, PTGS2 |
2.48236 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.48085 |
[BP] GO:0032230 |
positive regulation of synaptic transmission, GABAergic
|
CA2, CA7, PRKCE |
2.48085 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, AR, BCL2, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, PRKCB, PRKCD, PTGS2, PTPN1, SLC6A4, SRC, TERT, XDH |
2.47034 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, AR, BCL2, CDC25B, CSNK2A1, ESR1, F3, FLT3, GPER1, GRM1, GRM5, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.4644 |
[BP] GO:0090257 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM2, CHRM3, GPER1, PRKCA, PTGS2 |
2.44365 |
[BP] GO:1900543 |
None
|
ADRA2A, GRM3, GRM8, PPARA, PRKCA |
2.43652 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, FABP3, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
2.43493 |
[BP] GO:0090066 |
None
|
ADORA1, ADRA2A, CHRM1, CHRM3, GPER1, HRH1, PRKCD, PRKCE, PTGS2, SLC6A4 |
2.4238 |
[BP] GO:0045742 |
None
|
ADORA1, ADRA2A, GPER1, MMP9 |
2.41894 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX12, ALOX5, PTGS1, PTGS2 |
2.41894 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, PRKCD, SRC |
2.41571 |
[BP] GO:0045980 |
None
|
ADRA2A, GRM3, GRM8, PPARA, PRKCA |
2.41571 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.41571 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, FLT3, GRM5, PRKCD, PRKCE, PTPN1, SRC |
2.41465 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, AURKB, CDC25B, CYP1A1, GPER1, PRKCA, PRKCE, SLC6A4, SRC, TERT |
2.41265 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.39614 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, ALOX12, MET, PIK3CA, TRPV1 |
2.39614 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.38445 |
[BP] GO:0015695 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC47A1 |
2.38445 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, AR, BCL2, CDC25B, ESR1, F3, FLT3, GPER1, GRM1, GRM5, KDR, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, SRC, XDH |
2.38332 |
[BP] GO:0071383 |
None
|
AR, FLT3, GPER1, NR3C1, SRC |
2.36915 |
[BP] GO:0006109 |
regulation of carbohydrate metabolic process
|
ESRRB, GPER1, HRH1, PPARA, PRKCE, RORC, SRC |
2.36648 |
[BP] GO:1901186 |
None
|
ADORA1, ADRA2A, GPER1, MMP9 |
2.34607 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
GPER1, MMP2, MMP9, TERT |
2.34607 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, GPER1, PRKCE, PTGS2 |
2.34607 |
[BP] GO:0045934 |
None
|
ADRA2A, APEX1, AR, AURKB, ESR1, ESR2, ESRRA, FABP4, GPER1, GRM3, GRM8, MMP12, NR3C1, PPARA, PRKCA, RORC, SRC, TERT, TNKS, TNKS2, TRPV1 |
2.34607 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, GPER1, HCAR2, MMP12, PRKCE, SLC6A4, SRC, TRPV1 |
2.32259 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
2.32174 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, AR, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, ESR1, ESR2, F3, FABP4, FLT3, GPER1, GRM1, GRM3, GRM5, IGF1R, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TNKS, TRPV1, XDH |
2.32168 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.31844 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, NR3C1, PRKCE, SRC |
2.31482 |
[BP] GO:0032355 |
response to estradiol
|
CYP1A2, ESR1, ESRRA, GPER1, PTGS2, SLC6A4 |
2.29495 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6 |
2.27677 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, ESR1, GPER1, GRM1, GRM5, KCNH2, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.26141 |
[BP] GO:0051172 |
None
|
ADRA2A, APEX1, AR, AURKB, CSNK2A1, ESR1, ESR2, ESRRA, FABP4, GPER1, GRM3, GRM8, IGF1R, MMP12, MMP9, NR3C1, PPARA, PRKCA, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TRPV1, XDH |
2.26141 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
AR, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, HRH1, IGF1R, MET, MMP12, NR3C1, PGR, PPARA, PRKCD, PTGS2, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1 |
2.26141 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.26141 |
[BP] GO:0060748 |
None
|
AR, PGR |
2.26141 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.26141 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.26141 |
[BP] GO:0032227 |
negative regulation of synaptic transmission, dopaminergic
|
PTGS2, SLC6A4 |
2.26141 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.25658 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.25658 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX5, PTGS2 |
2.25658 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, ALOX12, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GPER1, GRM1, IGF1R, KDR, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
2.25422 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, GPER1, MMP2, MMP9, PTGS2, TERT |
2.24613 |
[BP] GO:0015850 |
None
|
CHRM5, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
2.22856 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.22732 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, HSD17B3, MMP2, MMP9, PGR, PTGS2, SLC6A4, SRC, TOP2A |
2.22732 |
[BP] GO:1901655 |
None
|
AKR1B1, AR, NR3C1, PRKCE, SRC |
2.22701 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, PRKCD, SRC |
2.22074 |
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, GRM5, PTPN1 |
2.22074 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, FABP3, HSD17B2, KDR, MMP2, PRKCE, PTGS2, SLC6A4, SRC |
2.2168 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
BCL2, CA2, CA7, ESR1, GPER1, GRIK5, GRM1, GRM5, PIK3CA, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.21453 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, PRKCD |
2.20691 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX12, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
2.19617 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.19499 |
[BP] GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress
|
BCL2, CYP1B1, PRKCD |
2.19499 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.19499 |
[BP] GO:0030818 |
None
|
ADRA2A, GRM3, GRM8, PRKCA |
2.19365 |
[BP] GO:0006836 |
None
|
SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
2.17632 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, MMP9, PRKCD, SRC |
2.13433 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.12674 |
[BP] GO:0090330 |
regulation of platelet aggregation
|
ALOX12, PRKCA, PRKCD |
2.12674 |
[BP] GO:0042136 |
neurotransmitter biosynthetic process
|
ACHE, CYP1B1, SLC22A2, SLC6A4 |
2.12666 |
[BP] GO:0030803 |
None
|
ADRA2A, GRM3, GRM8, PRKCA |
2.12666 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, ESR2, F10, F3, FLT3, GPER1, GRM1, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PIK3CB, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
2.11902 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, APEX1, AR, AURKB, BCL2, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GPER1, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
2.10973 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, BCL2, HCAR2, MET, PIK3CA, PPARA, PRKCG |
2.10551 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCL2, FLT3, HSD11B2, NR3C1, PTGS2 |
2.08245 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, ADRA2A, CA2, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, GPER1, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, PIK3CA, PIK3CB, SRC |
2.07509 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, AR, AURKB, BCL2, CA9, CDC25B, CHRM5, CSNK2A1, CYP1B1, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GPER1, GRM1, GRM3, GRM5, GRM8, HRH1, IGF1R, KDR, MET, MMP12, MMP9, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, XDH |
2.06669 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, FLT3, GRM1, IGF1R, PIK3CB, PRKCD, PTPN1, SRC |
2.06669 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.06591 |
[BP] GO:0030815 |
None
|
ADRA2A, GRM3, GRM8, PRKCA |
2.06591 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, AR, AXL, BCL2, CA2, CDK6, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HSD17B3, KDR, MMP9, PGR, PIK3CA, PIM1, PPARA, PTGS2, RORC, SRC, TYR |
2.04958 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, GPER1, HRH1, HSD11B2, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SLC6A2, SLC6A4, SRC, TERT, TOP2A, TRPV1 |
2.04958 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, FLT3, GRM1, GRM5, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC, TNKS |
2.04409 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSD17B3, SRC |
2.04128 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
2.04128 |
[BP] GO:1900372 |
None
|
ADRA2A, GRM3, GRM8, PRKCA |
2.03855 |
[BP] GO:0030809 |
None
|
ADRA2A, GRM3, GRM8, PRKCA |
2.03855 |
[BP] GO:0046626 |
regulation of insulin receptor signaling pathway
|
PRKCB, PRKCD, PTPN1, SRC |
2.03855 |
[BP] GO:0061041 |
regulation of wound healing
|
ADRA2A, ALOX12, F3, PRKCA, PRKCD, PRKCE |
2.03275 |
[BP] GO:1901374 |
None
|
SLC22A1, SLC22A2 |
2.02791 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.02791 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.02791 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.02791 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.02791 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, BCL2, CA2, CA7, ESR1, GPER1, GRIK5, GRM1, GRM5, PIK3CA, PIK3CB, PRKCB, PRKCE, TRPV1 |
2.02329 |
[BP] GO:0030800 |
None
|
ADRA2A, GRM3, GRM8, PRKCA |
2.02015 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, AURKB, BCL2, CDC25B, ESR1, F3, FLT3, GPER1, GRM1, GRM5, PIK3CA, PIK3CB, PRKCD, PRKCE, PTPN1, SRC, TERT, TNKS, XDH |
2.01611 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, GPER1, MMP9, PTGS2, SRC, XDH |
2.01611 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, FLT3, GRM1, GRM5, PIK3CA, PIK3CB, PRKCD, PTPN1, SRC |
2.00908 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALPI, ALPL, AR, AXL, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, ESR1, F10, F3, FLT3, GBA2, GLO1, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, IGF1R, KCNH2, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTPN1, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TERT, TRPV1 |
8.75914 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX12, ALOX5, ALPI, ALPL, AR, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, F10, F3, FLT3, FUT7, GBA2, GLO1, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, HSD11B1, HSD11B2, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MET, MMP2, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TRPV1, TYR |
8.4936 |
[CC] GO:0097060 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PRKCG, TRPV1 |
6.41171 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, ADRA2A, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, MET, PRKCG, PTGS2, SLC1A1, SLC22A1, SRC, TRPV1 |
6.30913 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, F10, F3, FLT3, GPER1, GRIA2, GRM1, GRM3, GRM5, GRM8, HRH1, IGF1R, KDR, MET, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4, TRPV1 |
6.02205 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PRKCG, SLC22A2, SLC6A4, SRC, TRPV1 |
5.41059 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA2A, ALPI, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, F10, F3, FLT3, FUT7, GBA2, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, HSD11B1, HSD11B2, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MET, MPEG1, NR3C2, PIK3CA, PIK3CB, PRKCG, PTGS1, PTGS2, PTPN1, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TRPV1, TYR |
5.33747 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, FLT3, GPER1, GRIA2, GRM1, GRM3, GRM5, GRM8, HRH1, IGF1R, KDR, MET, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4, TRPV1 |
4.77505 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, AXL, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, F10, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HRH1, IGF1R, KCNH2, KDR, MET, PRKCG, PTGS2, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4, SRC, TRPV1 |
4.45384 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
BCL2, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, F10, FLT3, GBA2, GPER1, GRIA2, HSD11B1, HSD11B2, HSD17B2, HSD17B3, NR3C2, PTGS1, PTGS2, PTPN1 |
4.35781 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, BCL2, CA4, CES1, CES2, CYP19A1, CYP2D6, FLT3, GBA2, GPER1, GRIK5, HSD17B3, KDR, PRKCA, PRKCD, PRKCE, PTGS2, PTPN1, XDH |
4.21134 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, GBA2, GPER1, GRIA2, HSD11B1, HSD11B2, HSD17B2, HSD17B3, NR3C2, PTGS1, PTGS2 |
3.81876 |
[CC] GO:0042734 |
None
|
GPER1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.79451 |
[CC] GO:0014069 |
None
|
ADORA1, CHRM1, GPER1, GRIK5, GRM1, GRM3, GRM5, PRKCG, SRC |
3.63287 |
[CC] GO:0099572 |
None
|
ADORA1, CHRM1, GPER1, GRIK5, GRM1, GRM3, GRM5, PRKCG, SRC |
3.63287 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, CHRM1, CHRM2, CHRM3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PRKCG, PTGS2, SLC6A2, SLC6A4, SRC |
3.491 |
[CC] GO:0045211 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM3, TRPV1 |
3.44259 |
[CC] GO:0098793 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, GPER1, GRIK5, SLC22A2, SLC6A4 |
3.29522 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, APEX1, AR, AURKB, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CDC25B, CDK6, CES1, CES2, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPER1, GRIA2, GRIA4, GRIK5, HRH1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, KCNH2, KDR, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
2.89135 |
[CC] GO:0097458 |
None
|
ADORA1, CA2, CHRM1, CHRM2, CHRM3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PRKCG, PTGS1, PTGS2, SLC22A2, SLC6A2, SLC6A4, SRC, TRPV1 |
2.4549 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, CDK6, CHRM1, CHRM2, CHRM3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PRKCG, PTGS2, SLC6A2, SLC6A4, SRC |
2.3923 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APEX1, CA4, GPER1, KCNH2, PRKCA, PRKCD, PRKCE, PRKCG, SRC, TNKS2, TYR |
2.25051 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, CA9, CHRM3, SLC22A1 |
2.22732 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, CDK6, CHRM1, CHRM2, CHRM3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PRKCG, PTGS2, SLC6A2, SLC6A4, SRC |
2.12827 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.02095 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX5, ALPI, AOX1, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, TNKS, TYR, XDH |
22.2773 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
15.0015 |
[MF] GO:0008270 |
zinc ion binding
|
ALPI, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PPARA, PRKCA, PRKCB, PRKCG, PTPN1, RORC, TNKS |
12.8269 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPI, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES1, CES2, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, F10, F3, FLT3, FUT7, GBA2, GLO1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
11.3515 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX5, ALPI, ALPL, AOX1, APEX1, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
11.1407 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD11B2, HSD17B1, NR3C1, NR3C2, PGR, RORC, SHBG |
11.1151 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX5, ALPI, ALPL, AOX1, APEX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
11.04 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX5, ALPI, ALPL, AOX1, APEX1, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SLC6A2, SLC6A4, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
10.3297 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR3C1, NR3C2, PGR, PPARA, RORC |
10.2505 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TRPV1 |
10.2505 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.2616 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, CDK6, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TRPV1 |
9.2537 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
9.21133 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, RORC, TRPV1 |
8.97831 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, IGF1R, KCNH2, KDR, MET, NR3C1, NR3C2, PGR, PPARA, PRKCE, RORC, TRPV1 |
8.55151 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, NQO2, PTGS1, PTGS2, TYR, XDH |
8.55151 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PGR, PPARA, RORC |
8.28325 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, PGR, PPARA, RORC |
8.28325 |
[MF] GO:0005329 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
7.77008 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
7.32776 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.20749 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, XDH |
7.19242 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, SRC |
7.07179 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, SRC |
6.78093 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, FLT3, IGF1R, KDR, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SLC6A4, SRC, TOP2A, TRPV1 |
6.75005 |
[MF] GO:0008504 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
6.62397 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HRH1 |
6.60453 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 |
6.60453 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, CHRM3, GPER1, HSD17B1, IGF1R, NQO2, NR3C1, SHBG |
6.34214 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGS1, PTGS2, TYR |
6.32321 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GPER1, HSD11B2, HSD17B1, NR3C1, NR3C2, PGR, PPARA, RORC, SHBG, TRPV1 |
6.25704 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
6.11217 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, TYR |
5.99247 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
5.91079 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6 |
5.81333 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD11B2, HSD17B1, NQO2, PTGS1, PTGS2, SRC, XDH |
5.39933 |
[MF] GO:0004697 |
None
|
PRKCA, PRKCB, PRKCD, PRKCE, PRKCG |
5.33747 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19, CYP2D6 |
5.16378 |
[MF] GO:0015238 |
None
|
SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4 |
4.91463 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, XDH |
4.82104 |
[MF] GO:0005333 |
None
|
SLC22A1, SLC22A2, SLC6A2 |
4.58726 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, IGF1R, KDR, MET, TRPV1 |
4.56641 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, CHRM1, CHRM2, CHRM3, CHRM5, F3, FLT3, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, IGF1R, KDR, MET, TRPV1 |
4.56641 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.49161 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB, PRKCD |
4.35977 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.26497 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.1369 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
4.12776 |
[MF] GO:0004698 |
None
|
PRKCA, PRKCB, PRKCG |
4.08577 |
[MF] GO:0008519 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
4.07777 |
[MF] GO:0008227 |
None
|
ADRA2A, CHRM1, CHRM2, CHRM3, CHRM5, HRH1 |
3.99532 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
3.72993 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC |
3.63506 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, HRH1 |
3.60038 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.53673 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, IGF1R, KCNH2, KDR, MET, PIK3CA, PIK3CB, PIM1, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, SRC, TERT |
3.27795 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
3.27729 |
[MF] GO:1901618 |
None
|
SLC22A1, SLC22A2, SLC22A3, SLC6A2, SLC6A4 |
3.27729 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, ALPI, AR, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, ESR1, ESR2, ESRRB, F3, GRM5, KCNH2, MET, NR3C1, PGR, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PTGS2, PTPN1, SLC6A4, SRC, TNKS2, TOP2A |
3.24381 |
[MF] GO:0005326 |
None
|
SLC1A1, SLC22A1, SLC22A2, SLC6A2, SLC6A4 |
2.92352 |
[MF] GO:0015651 |
None
|
SLC22A1, SLC22A2, SLC22A3 |
2.91987 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, BCL2, CSNK2A1, ESR1, ESR2, FLT3, GRIK5, IGF1R, KCNH2, KDR, MET, MMP9, NQO2, PGR, PTGS2, SLC22A1, SLC6A4, TERT, TOP2A, TRPV1, TYR, XDH |
2.83242 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
2.71688 |
[MF] GO:0009931 |
None
|
PRKCA, PRKCB, PRKCG |
2.66488 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.66488 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.64477 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.64477 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.64477 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.64477 |
[MF] GO:0035403 |
None
|
PRKCA, PRKCB |
2.64477 |
[MF] GO:0099094 |
None
|
GRIA2, GRIA4, GRIK5, KCNH2, TRPV1 |
2.5923 |
[MF] GO:0010857 |
None
|
PRKCA, PRKCB, PRKCG |
2.57598 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, NQO2, XDH |
2.57598 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, PRKCD, SRC |
2.27276 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.26141 |
[MF] GO:0015307 |
None
|
SLC47A1, SLC47A2 |
2.26141 |
[MF] GO:1901375 |
None
|
SLC22A1, SLC22A2 |
2.26141 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.26141 |
[MF] GO:0005277 |
None
|
SLC22A1, SLC22A2 |
2.26141 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.26141 |
[MF] GO:0008513 |
None
|
SLC22A1, SLC22A2 |
2.26141 |
[MF] GO:0004699 |
None
|
PRKCD, PRKCE |
2.26141 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.26141 |
[MF] GO:0008392 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.19499 |
[MF] GO:0008391 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.19499 |
[MF] GO:0035173 |
histone kinase activity
|
AURKB, PRKCA, PRKCB |
2.19499 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.19365 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, ALPI, ALPL, APEX1, CA1, CA2, CDC25B, CES1, CES2, CHRM1, CHRM3, CHRM5, PTPN1 |
2.17632 |
[MF] GO:0008324 |
None
|
GRIA2, GRIA4, GRIK5, KCNH2, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, TRPV1 |
2.17549 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.06591 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.06591 |
[MF] GO:0005231 |
None
|
GRIA2, GRIA4, GRIK5, TRPV1 |
2.06591 |
[MF] GO:0008081 |
None
|
ADORA1, APEX1, CHRM1, CHRM3, CHRM5 |
2.03275 |
[MF] GO:0003674 |
molecular_function
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX12, ALOX5, ALPI, ALPL, AOX1, APEX1, AR, AURKB, AXL, BCL2, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CDK6, CES1, CES2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GPER1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HRH1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KCNH2, KDR, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NR3C1, NR3C2, PGR, PIK3CA, PIK3CB, PIM1, PPARA, PRKCA, PRKCB, PRKCD, PRKCE, PRKCG, PTGS1, PTGS2, PTPN1, RORC, SHBG, SLC1A1, SLC22A1, SLC22A2, SLC22A3, SLC47A1, SLC47A2, SLC6A2, SLC6A4, SRC, TERT, TNKS, TNKS2, TOP2A, TRPV1, TYR, XDH |
2.02954 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.02791 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.02791 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.02791 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.02791 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.02095 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SLC6A4, SRC |
2.02095 |